Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Khalpey AI Lab is a healthcare technology organization focused on integrating artificial intelligence with cardiothoracic surgery and regenerative medicine. Founded by Dr. Zain Khalpey, the lab specializes in creating "digital twins" to predict patient outcomes and optimize surgical interventions. Their work spans predictive analytics for heart failure, organ preservation, and the application of regenerative therapies like exosomes and stem cells. The lab aims to personalize medicine by leveraging multi-omic data and real-time physiological monitoring to improve patient longevity and surgical success rates. They collaborate with clinical institutions to implement AI-driven decision support systems in high-acuity surgical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Khalpey AI Lab.